ERn Financial LLC Acquires 61 Shares of HCA Healthcare, Inc. (NYSE:HCA)

ERn Financial LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,875 shares of the company’s stock after purchasing an additional 61 shares during the quarter. ERn Financial LLC’s holdings in HCA Healthcare were worth $563,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of the company. FMR LLC raised its holdings in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Darsana Capital Partners LP raised its position in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Meritage Group LP bought a new stake in HCA Healthcare during the 3rd quarter valued at $150,548,000. Holocene Advisors LP lifted its position in HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after acquiring an additional 208,015 shares in the last quarter. Finally, Nordea Investment Management AB raised its stake in shares of HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after purchasing an additional 193,075 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.2 %

Shares of HCA stock opened at $306.34 on Thursday. The business has a 50-day moving average of $319.34 and a 200 day moving average of $353.44. HCA Healthcare, Inc. has a 1-year low of $276.50 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The stock has a market capitalization of $77.60 billion, a PE ratio of 13.76, a P/E/G ratio of 1.03 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insider Activity at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Finally, Barclays lowered their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.